Onyx Enrolls FOCUS Patients – Analyst Blog Onyx Pharmaceuticals, Inc. ( ONXX ) recently announced that it has finished enrolling patients for the phase III FOCUS (Car F ilz O mib for Advan C ed Refractory M U ltiple
Nike Lifted to Neutral – Analyst Blog Our long term recommendation on leading sports gear retailer, Nike Inc.